Plain-English translation of NCT06671496 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it can help people with psoriatic arthritis—a condition that causes painful, swollen joints and skin rashes. About 600 people will participate, and some will receive the medication while others receive a placebo (a pill with no active ingredient). The study will last about 60 weeks to measure how well this treatment works and how safe it is.
Psoriatic arthritis can be difficult to treat, especially for people whose symptoms don't improve with current medicines or who have tried biologic treatments without success. Researchers are testing this medication to see if it offers a new option for people who need better control of their joint pain and swelling.
You likely qualify if…
You likely don't qualify if…
You would take a tablet by mouth once daily for up to 52 weeks. Some participants will receive the new medication from the start, while others will receive a placebo for the first 16 weeks and then switch to the medication. You'll visit the study center multiple times over the 60-week period so doctors can check how your joints and skin are responding and monitor for any side effects.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States